Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Net Receivables

$441.80M

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Net Receivables

Latest reported$441.80Mperiod endingJun 30, 2026

BIO Quarterly Net Receivables ($23.10M → $441.80M)

Quarterly net receivables

High-resolution chart · PNG

BIO net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Net Receivables — Quarterly (USD)
Period ending	Net Receivables (USD)
Jun 30, 2026	441,800,000
Mar 31, 2026	426,200,000
Dec 31, 2025	472,500,000
Sep 30, 2025	474,200,000
Jun 30, 2025	469,900,000
Mar 31, 2025	424,700,000
Dec 31, 2024	452,500,000
Sep 30, 2024	461,940,000
Jun 30, 2024	445,506,000
Mar 31, 2024	444,809,000
Dec 31, 2023	489,017,000
Sep 30, 2023	457,402,000
Jun 30, 2023	491,575,000
Mar 31, 2023	498,273,000
Dec 31, 2022	494,645,000
Sep 30, 2022	432,302,000
Jun 30, 2022	450,324,000
Mar 31, 2022	464,107,000
Dec 31, 2021	423,537,000
Sep 30, 2021	417,714,000
Jun 30, 2021	399,307,000
Mar 31, 2021	408,137,000
Dec 31, 2020	419,424,000
Sep 30, 2020	402,241,000
Jun 30, 2020	369,767,000
Mar 31, 2020	380,476,000
Dec 31, 2019	392,672,000
Sep 30, 2019	356,025,000
Jun 30, 2019	377,904,000
Mar 31, 2019	391,699,000
Dec 31, 2018	392,443,000
Sep 30, 2018	381,526,000
Jun 30, 2018	404,091,000
Mar 31, 2018	430,361,000
Dec 31, 2017	464,847,000
Sep 30, 2017	419,708,000
Jun 30, 2017	392,842,000
Mar 31, 2017	373,443,000
Dec 31, 2016	372,348,000
Sep 30, 2016	367,662,000
Jun 30, 2016	366,281,000
Mar 31, 2016	381,100,000
Dec 31, 2015	391,485,000
Sep 30, 2015	341,548,000
Jun 30, 2015	354,161,000
Mar 31, 2015	342,223,000
Dec 31, 2014	377,640,000
Sep 30, 2014	354,401,000
Jun 30, 2014	378,891,000
Mar 31, 2014	383,928,000
Dec 31, 2013	422,660,000
Sep 30, 2013	383,471,000
Jun 30, 2013	395,974,000
Mar 31, 2013	377,548,000
Dec 31, 2012	398,739,000
Sep 30, 2012	375,800,000
Jun 30, 2012	373,817,000
Mar 31, 2012	387,619,000
Dec 31, 2011	398,674,000
Sep 30, 2011	375,031,000
Jun 30, 2011	394,913,000
Mar 31, 2011	388,554,000
Dec 31, 2010	387,996,000
Sep 30, 2010	368,603,000
Jun 30, 2010	335,354,000
Mar 31, 2010	344,989,000
Dec 31, 2009	345,734,000
Sep 30, 2009	350,762,000
Jun 30, 2009	335,828,000
Mar 31, 2009	326,307,000
Dec 31, 2008	339,653,000
Sep 30, 2008	348,253,000
Jun 30, 2008	376,985,000
Mar 31, 2008	366,509,000
Dec 31, 2007	358,076,000
Sep 30, 2007	303,201,000
Jun 30, 2007	303,266,000
Mar 31, 2007	290,116,000
Dec 31, 2006	292,970,000
Sep 30, 2006	273,367,000
Jun 30, 2006	273,014,000
Mar 31, 2006	259,231,000
Dec 31, 2005	247,192,000
Sep 30, 2005	244,466,000
Jun 30, 2005	243,387,000
Mar 31, 2005	250,968,000
Dec 31, 2004	261,243,000
Sep 30, 2004	228,186,000
Jun 30, 2004	234,003,000
Mar 31, 2004	228,925,000
Dec 31, 2003	234,085,000
Sep 30, 2003	217,674,000
Jun 30, 2003	211,922,000
Mar 31, 2003	213,955,000
Dec 31, 2002	212,282,000
Sep 30, 2002	201,261,000
Jun 30, 2002	199,973,000
Mar 31, 2002	196,004,000
Dec 31, 2001	194,400,000
Sep 30, 2001	186,394,000